PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
03/31/2026
Back to search
Official data from USPTO
GENOMIC EXPRESSION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
04/01/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
07/31/2018
Registration date
01/07/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2020
Last transaction
04/01/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2012-11-00
First use in commerce
2012-11-00
Drawing code
3
Owner type
03
Owner location
Beverly, MA, US
Examiner
FENNESSY, EDWARD JOHN
Current location
Historical data usage
Mark description
The mark consists of the words "GENOMIC EXPRESSION". The letter "X" in the word "EXPRESSION" appears as a design with a dot above the letter "X" creating a human stick figure with a head, arms and legs.
Holders and representatives
Holders
Genomic Expression Inc.
Representatives
Genomic Expression Inc.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
genetic mapping for medical and scientific research purposes; providing scientific analysis of genetic sequences; structural and functional analysis of genomes; genome amplification; development of new technology for others in the field of genomics; Providing medical research and scientific research information in the field of oncology and other diseases via the Internet; Providing laboratory research services in the field of gene expressioncancer biology; molecular biology and genomics servicesnucleic acid isolation and purificationRNA sequencinggenotypinggenetic stability testingquantitative polymerase chain reaction analysis
Class 44
Providing a website featuring information about genetic diagnostic solutionsRNA and DNA analysis for medical diagnostic and treatment purposes; consulting services in the field of genetic diagnostic solutionsRNA sequencing for medical diagnostic and treatment purposes
Publications
History of USPTO decisions and trademark events.
26 publications found
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/31/2026
E815
TEAS SECTION 8 & 15 RECEIVED
01/06/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/07/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2019
PUBO
PUBLISHED FOR OPPOSITION
10/22/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2019
ALIE
ASSIGNED TO LIE
09/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/15/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/11/2019
GNRT
NON-FINAL ACTION E-MAILED
06/11/2019
CNRT
NON-FINAL ACTION WRITTEN
06/11/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2019
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
11/19/2018
GPRA
PRIORITY ACTION E-MAILED
11/19/2018
CPRA
PRIORITY ACTION WRITTEN
11/19/2018
DOCK
ASSIGNED TO EXAMINER
11/16/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/07/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/06/2018
NWAP
NEW APPLICATION ENTERED
08/03/2018
Continuous trademark protection
Get notified about every new filing that threatens GENOMIC EXPRESSION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.